CareDx, Inc. (NASDAQ: CDNA) Stock Information | RedChip

CareDx, Inc. (NASDAQ: CDNA)


$20.6500
+0.0400 ( 0% ) 154.7K

CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre-and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates major revenue from the Testing services.

Market Data


Open


$20.6500

Previous close


$20.6100

Volume


154.7K

Market cap


$1.11B

Day range


$20.4030 - $21.4800

52 week range


$7.4200 - $34.8400

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Jan 16, 2024
8-k 8K-related 57 Jan 09, 2024
4 Insider transactions 1 Jan 05, 2024
4 Insider transactions 1 Jan 05, 2024
4 Insider transactions 1 Jan 05, 2024
4 Insider transactions 1 Jan 04, 2024
8-k 8K-related 13 Dec 22, 2023

Latest News